GoHealth Inc.

GoHealth Inc. (GOCO) Market Cap

GoHealth Inc. has a market capitalization of .

No quote data available.

CEO: Vijay Kotte

Sector: Financial Services

Industry: Insurance - Brokers

IPO Date: 2020-07-15

Website: https://www.gohealth.com

GoHealth Inc. (GOCO) - Company Information

Market Cap: -|Sector: Financial Services

Company Profile

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance purchasing behavior to reimagine the process of matching a health plan for a consumer’s specific needs. It also provides Medicare plans, including Medicare advantage, Medicare supplement, prescription drug plans, and special needs plans. In addition, the company offers partner marketing services. It sells its products through internal and external agencies, as well as its platform. The company was founded in 2001 and is headquartered in Chicago, Illinois.

Analyst Sentiment

63%
Buy

From 5 Active Polls

1Y Forecast: $5.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$5

Median

$5

High Bound

$5

Average

$5

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$5.00
▲ +1539.34% Upside
Low Target
$5.00
1539% Risk
Median Target
$5.00
1539% Mid
High Target
$5.00
1539% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 GOHEALTH INC CLASS A (GOCO) — Investment Overview

🧩 Business Model Overview

GoHealth operates as an insurance distribution and enrollment platform, connecting consumers with health insurance options (notably Medicare and individual market plans) through a mix of digital and assisted channels. The value chain begins with demand generation (marketing and lead acquisition), continues through qualification and plan selection support, and culminates in carrier contracting and enrollment processing. The operating model blends consumer-facing workflow (eligibility screening, plan comparison, application support) with payer-facing execution (contracting, compliance, and accurate submission). The result is a recurring annual “enrollment event” engine: consumers revisit coverage each plan year, and GoHealth supplies leads and enrollment assistance to health plan issuers.

💰 Revenue Streams & Monetisation Model

Revenue is primarily driven by commissions and fees tied to successful enrollments and related distribution services. Monetisation is therefore heavily dependent on conversion from lead to enrolled policy and on the economics of payer contracting (commission rates, bonus structures, and administrative/payment terms). Margin typically hinges on:

  • Lead unit economics: cost per qualified lead versus downstream conversion to enrolled members.
  • Operating leverage: scaling call center and technology operations to serve more applications without proportional cost growth.
  • Payer mix and plan economics: the mix of products (e.g., Medicare Advantage versus other offerings) and how commission/contract terms translate into contribution margin.

While each consumer enrollment is a discrete transaction, the annual re-enrollment cycle can create a repeatable revenue pattern as the company re-engages the same demographic pools over time.

🧠 Competitive Advantages & Market Positioning

GoHealth’s moat is best characterized as an integrated enrollment ecosystem supported by operational scale and proprietary execution capabilities. Although customers can switch plans each year, the company’s competitive strength is less about “consumer lock-in” and more about repeatable conversion performance and lower cost-to-enroll.

  • Integrated ecosystem (execution + compliance): Enrollment involves eligibility rules, plan fit decisions, and submission accuracy—an environment where operational rigor and process reliability create barriers to entry.
  • Scale in distribution and servicing: Marketing spend, call center capacity, and technology workflow must be calibrated to conversion rates; scale can lower effective cost per enrollment and improve speed-to-application.
  • Data and workflow learning (intangible asset): Over time, pattern recognition around eligibility and plan selection improves qualification efficiency and reduces avoidable drop-off.

Competitive benchmarking:

  • eHealth: Another prominent online health insurance marketplace/brokerage channel. GoHealth tends to emphasize Medicare/individual-market enrollment operations with a heavier focus on assisted conversion workflows.
  • HealthSherpa: A technology- and platform-oriented enrollment provider often associated with ACA marketplaces. GoHealth’s relative positioning leans toward combining technology with operational servicing capacity and payer contracting execution.
  • HealthMarkets: A traditional insurance distribution/broker channel with a strong agent network. GoHealth competes by digital-led lead generation plus standardized enrollment operations rather than relying primarily on agent-led sourcing.

Across these rivals, the key distinction is that GoHealth’s differentiation relies on end-to-end enrollment execution—not solely consumer-facing software—and on the economics of converting demand into compliant enrollments.

🚀 Multi-Year Growth Drivers

  • Demographic and utilization tailwinds: Aging demographics and higher healthcare plan complexity increase the need for assisted plan selection and navigation.
  • Continued Medicare Advantage penetration: As more beneficiaries choose plans with structured benefits, enrollment support and carrier distribution remain structurally relevant.
  • Digital-assisted distribution expansion: Consumers increasingly start online but still value guided enrollment for eligibility and plan fit—supporting hybrid channels.
  • Issuer reliance on qualified distribution: Health plan issuers benefit from scalable channels that can deliver compliant enrollments; distribution capacity can become more valuable when operational accuracy and conversion matter.

Over a 5–10 year horizon, the addressable market expands with both beneficiary growth and plan-choice complexity, while competitive dynamics favor providers who maintain strong conversion and compliant execution at disciplined lead economics.

⚠ Risk Factors to Monitor

  • Regulatory and compliance risk: Insurance marketing, lead generation practices, and enrollment disclosures are subject to state and federal oversight; compliance failures can constrain operations or increase costs.
  • Payer contracting and commission pressure: Health plans can renegotiate commission structures, impose service requirements, or shift distribution economics, affecting margins.
  • Lead generation cost inflation: Rising customer acquisition costs without proportional conversion gains can compress contribution margin.
  • Operational concentration risk: Outcomes depend on call center capacity, technology workflow reliability, and enrollment accuracy; disruptions can reduce conversion.
  • Data privacy and cybersecurity: Enrollment platforms process sensitive information, making information security a persistent operational risk.

📊 Valuation & Market View

Market participants typically value health insurance distribution platforms using revenue-centric multiples (often EV/Sales) and, where meaningful, cash flow and contribution margin metrics. The variables that most influence valuation tend to be:

  • Conversion efficiency: qualified lead-to-enrollment rates and funnel durability across plan cycles.
  • Unit economics stability: sustainable acquisition costs relative to commissions/fees.
  • Operating leverage: evidence that fixed costs (technology and servicing infrastructure) scale with enrollments.
  • Balance between growth and profitability: sustainable growth without eroding contribution margin.

Because revenue is closely tied to enrollment outcomes and payer terms, valuation is sensitive to changes in contracting economics, regulatory constraints on marketing and processing, and the stability of acquisition funnel performance.

🔍 Investment Takeaway

GoHealth’s long-term investment case rests on an integrated insurance enrollment ecosystem that converts demand into compliant enrollments at scale. The structural value is not simple “customer stickiness,” but rather operational execution, workflow learning, and scale-driven economics that can be difficult for pure-play channels or less integrated brokers to replicate. The primary debate centers on the durability of conversion economics and payer distribution terms under regulatory and competitive pressure.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"GOCO reported Q1’26 revenue of $11.9M and net income of -$37.2M (EPS -$2.36). YoY (vs Q1’25) revenue fell sharply (from $221.0M to $11.9M, -94.6%), and net loss widened (from -$4.4M to -$37.2M). QoQ (vs Q4’25) revenue dipped (from $12.6M to $11.9M, -5.7%), while the loss worsened (net income -$32.6M to -$37.2M, -14.1%). Profitability remains deeply negative: operating margin was -2.92 in Q1’26 (still loss-making, though the magnitude improved vs Q4’25’s operating margin of -2.55 was not an improvement—losses remained significant). Cash flow quality is mixed. Despite a net loss, Q1’26 operating cash flow was +$7.0M, lifting cash to $39.9M. However, the company had materially negative operating cash flow in Q4’25 (-$39.1M), indicating volatility rather than stabilization. The balance sheet shows weakening equity (total stockholders’ equity ~+$0.7M vs +$94.8M in Q4’25), with total debt rising to ~$37.4M from Q4’25’s much higher level, while retained earnings remain heavily negative. Total shareholder return is very weak. The stock price is $1.15 with a -89.6% 1Y change, implying severe capital depreciation; no dividends are paid and there are no buybacks reported. Analyst consensus price target is $5, above the current price, but current fundamentals and cash volatility limit confidence."

Revenue Growth

Neutral

Revenue decreased -94.6% YoY (Q1’25 $221.0M to Q1’26 $11.9M) and -5.7% QoQ (Q4’25 $12.6M to Q1’26 $11.9M), indicating a deteriorating top line despite modest sequential decline.

Profitability

Neutral

Net income worsened to -$37.2M in Q1’26 (YoY: -$4.4M to -$37.2M). Margins remain negative: operating margin -2.92 in Q1’26 versus -2.55 in Q4’25—losses persist without a clear improvement trend.

Cash Flow Quality

Neutral

Operating cash flow turned positive in Q1’26 (+$7.0M) versus Q4’25 (-$39.1M), but volatility is high and net income is still deeply negative. No dividends; no meaningful buybacks reported.

Leverage & Balance Sheet

Neutral

Cash is $39.9M. However, equity deteriorated sharply (total stockholders’ equity +$0.7M in Q1’26 vs +$94.8M in Q4’25), and retained earnings remain very negative, reducing resilience.

Shareholder Returns

Neutral

Stock performance is severely negative: price is $1.15 with -89.6% 1Y change. With no dividend yield and no evidence of sustained buyback support, total shareholder returns are poor.

Analyst Sentiment & Valuation

Caution

Consensus target is $5 versus current $1.15 (upside implied), but the sharply worsening YoY fundamentals and equity drawdown limit the reliability of valuation support.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Management (Vijay) frames Q3 as a disciplined, early pullback from Medicare Advantage volume in response to carriers prioritizing retention and unit economics. They repeatedly argue the MA slow/contracting trajectory is not “irrational” and cite concrete carrier behaviors: tighter commissions, noncommissionable/suppressed preferred products, elimination of low-margin plans, and midstream changes through OEP/SEP. The business pivot to GoHealthProtect is positioned as an offsetting retention engine given Medicare seasonality. Analyst pressure focused on (1) how long the 12–24 month trough lasts and (2) cash and re-ramp feasibility. The hard numbers provided were liquidity: ~$32M cash at end of Q3 and ~$40M of new money under a super-priority facility with multiple draw triggers. The subtext in Q&A is that re-entry depends on predictable carrier economics/STAR stabilization; if wrong, the downside could be stranded upfront cash without year-one cash-on-cash returns.

AI IconGrowth Catalysts

  • GoHealthProtect growth supporting retention during MA seasonality (Guaranteed Acceptance peaks/valleys offset versus MA)
  • Continued leadership in Medicare Advantage Special Needs Plans (SN P) as carriers reallocate toward SN P options
  • AI/automation investment to improve agent effectiveness and member retention while overhead reduced

Business Development

  • Carrier partners supporting GoHealthProtect (no specific carrier names provided in the transcript)

AI IconFinancial Highlights

  • Cash balance: approximately $32 million at end of Q3 (per management filing reference)
  • Super-priority term loan: $40 million of new money with multiple draw opportunities during Q3 (triggered by time/date)
  • No EPS/revenue beats/misses or bps margin changes were provided in the supplied transcript excerpt

AI IconCapital Funding

  • Super-priority lender facility: $40 million new capital available to draw (multiple opportunities/trigger points in Q3)
  • Management emphasis on liquidity planning to maintain covenant compliance and preserve optionality through re-ramp capability

AI IconStrategy & Ops

  • Intentionally scaled back Medicare Advantage (MA) new enrollment earlier in the year due to tightening plan economics: retention/stable member profiles prioritized over expansion
  • Shifted capacity into GoHealthProtect during SEP; targeted retention rather than unit-economics-negative incremental MA volume
  • Retention mechanics: stopped the “queue” to prevent agents from being distracted by new-sale leads; focused follow-ups for existing/back-book consumers
  • Compensation model adjustments tied to retention/quality metrics (Plan Fit Save model referenced and “doubled down”)
  • Automation/technology standardization to shorten agent ramp time: referenced improvement from up to 16 weeks to materially faster onboarding; TeleQuote team brought on within ~2 weeks and doubled production

AI IconMarket Outlook

  • 12–24 month view: management expects health plans to stabilize cost structures, double down on STAR scores, and obtain appropriate federal rate adjustments; then re-align with GoHealth’s historically aligned MA needs
  • AEP/OEP/SEP pacing: in the current AEP, more MA during the peak closing portion; then return focus to Guaranteed Acceptance/GoHealthProtect post-peak; oscillate across OEP and beyond
  • Ongoing uncertainty watch: management expects possible suppression/commission changes midstream through OEP and into SEP for 2026 plan year offerings

AI IconRisks & Headwinds

  • Carrier actions compress economics: reduced prefunded marketing, reduced/tightened broker compensation, and some consumer-preferred plans made noncommissionable or suppressed
  • Health plan scaling/termination of low-margin plans and consolidation effects reduce addressable MA volume
  • Revenue LTV/cash-flow risk: management reiterated that year-one renewal assumptions are critical; disruption increases uncertainty around first-renewal cash-on-cash returns
  • MA market profitability and STAR score headwinds: outsize growth winners can face profitability challenges that translate into STAR onboarding/medical cost issues (noted as a lesson across major plans 2021–2022)
  • Re-ramp risk mitigation: ramp has historically been a cash-burn driver; mitigated via standardized AI/automation/training to re-ramp faster when line of sight returns

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the GOCO Q3 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — GoHealth Inc. (GOCO) Financial Profile